bit.bio launches first supply of consistent, scalable, human muscle cells
Highly consistent and scalable supply of lab grown human skeletal muscle cells provide an effective and biologically relevant tool for research and drug development
Highly consistent and scalable supply of lab grown human skeletal muscle cells provide an effective and biologically relevant tool for research and drug development
Watch this on-demand webinar to discover Abcam’s manufacturing workflow for producing bioactive proteins
Including a new section for embedded organoid assays, and new data on mitochondrial membrane potential assays and phagocytosis assays
Abcam scientist, Dr. Jimmy Theriault, discusses how to determine if proteins are functionally active using cell-based and biochemical assays
Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using EUROIMMUN tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection
DNA/RNA Shield – DirectDetect reagent eliminates RNA extraction for rapid deployment of COVID-19 tests
The kits have been developed based on the traditional PROGEN ELISA kits which have already earned reference standard status in gene therapy centers worldwide
Newly launched PAXgene Saliva Collector stabilizes collected sample to avoid preanalytical errors and thereby increases reproducibility and reliability of results
Industry expert John Radke reveals how a reliable and transparent supply chain partner can be critical to weathering turbulent times
Nobelpharma will use ProBioGen’s cell-based production platform AGE1.CR.pIX to develop their lead vaccine
Will enable cancer researchers to accelerate identification and optimization of therapeutic leads by better decoding KRAS mutations present in 25% of tumors
From tackling COVID-19 variants to therapeutic discovery, novel organoids and more, advance your assay research with these exclusive interviews and free resources
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
AMSBIO's new range avoid the need to source an expensive therapeutic product and enable fast and inexpensive assay development
The tool enables accurate modelling of the human colon and the mucosal barrier
This transaction will expand BioIVT’s biospecimen collection network by approximately 150 sites in the US, UK, and Europe and broaden its offerings for drug and diagnostic developers
The provision of high-quality cells that are known to grow successfully in 3D culture will help fast track organ-on-a-chip (OOC) adoption and customer research
New application notes, videos and products
Antibody expert, Dr. Chelcie Eller, shares how to achieve reliable and reproducible high-throughput drug and biomarker screening
The technology makes million-cell experiments routinely accessible for the first time
Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment
MIT engineers design the first synthetic circuit that consists entirely of fast, reversible protein-protein interactions
The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity